Skip to main content
Erschienen in: AIDS and Behavior 2/2017

08.12.2016 | Original Paper

Factors Associated with HIV Testing Among Participants from Substance Use Disorder Treatment Programs in the US: A Machine Learning Approach

verfasst von: Yue Pan, Hongmei Liu, Lisa R. Metsch, Daniel J. Feaster

Erschienen in: AIDS and Behavior | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

HIV testing is the foundation for consolidated HIV treatment and prevention. In this study, we aim to discover the most relevant variables for predicting HIV testing uptake among substance users in substance use disorder treatment programs by applying random forest (RF), a robust multivariate statistical learning method. We also provide a descriptive introduction to this method for those who are unfamiliar with it. We used data from the National Institute on Drug Abuse Clinical Trials Network HIV testing and counseling study (CTN-0032). A total of 1281 HIV-negative or status unknown participants from 12 US community-based substance use disorder treatment programs were included and were randomized into three HIV testing and counseling treatment groups. The a priori primary outcome was self-reported receipt of HIV test results. Classification accuracy of RF was compared to logistic regression, a standard statistical approach for binary outcomes. Variable importance measures for the RF model were used to select the most relevant variables. RF based models produced much higher classification accuracy than those based on logistic regression. Treatment group is the most important predictor among all covariates, with a variable importance index of 12.9%. RF variable importance revealed that several types of condomless sex behaviors, condom use self-efficacy and attitudes towards condom use, and level of depression are the most important predictors of receipt of HIV testing results. There is a non-linear negative relationship between count of condomless sex acts and the receipt of HIV testing. In conclusion, RF seems promising in discovering important factors related to HIV testing uptake among large numbers of predictors and should be encouraged in future HIV prevention and treatment research and intervention program evaluations.
Literatur
2.
Zurück zum Zitat Hall HI, An Q, Tang T, et al. Prevalence of diagnosed and undiagnosed HIV infection—United States, 2008–2012. MMWR Morb Mortal Wkly Rep. 2015;26:657–62. Hall HI, An Q, Tang T, et al. Prevalence of diagnosed and undiagnosed HIV infection—United States, 2008–2012. MMWR Morb Mortal Wkly Rep. 2015;26:657–62.
4.
Zurück zum Zitat Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS. 2012;26(7):893–6.CrossRefPubMed Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS. 2012;26(7):893–6.CrossRefPubMed
5.
Zurück zum Zitat Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. Recommendations and reports: morbidity and mortality weekly report. Recommendations and reports/Centers for Disease Control. 2006;55(RR-14):1–17; quiz CE11-14. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. Recommendations and reports: morbidity and mortality weekly report. Recommendations and reports/Centers for Disease Control. 2006;55(RR-14):1–17; quiz CE11-14.
6.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC). Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the US Department of Health and Human Services. MMWR. Recommendations and reports: morbidity and mortality weekly report. Recommendations and reports/Centers for Disease Control. 2012;61(RR-5):1. Centers for Disease Control and Prevention (CDC). Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the US Department of Health and Human Services. MMWR. Recommendations and reports: morbidity and mortality weekly report. Recommendations and reports/Centers for Disease Control. 2012;61(RR-5):1.
9.
Zurück zum Zitat King KM, Nguyen HV, Kosterman R, Bailey JA, Hawkins JD. Co-occurrence of sexual risk behaviors and substance use across emerging adulthood: evidence for state- and trait-level associations. Addiction. 2012;107(7):1288–96.CrossRefPubMedPubMedCentral King KM, Nguyen HV, Kosterman R, Bailey JA, Hawkins JD. Co-occurrence of sexual risk behaviors and substance use across emerging adulthood: evidence for state- and trait-level associations. Addiction. 2012;107(7):1288–96.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Raj A, Saitz R, Cheng DM, Winter M, Samet JH. Associations between alcohol, heroin, and cocaine use and high risk sexual behaviors among detoxification patients. Am J Drug Alcohol Abuse. 2007;33(1):169–78.CrossRefPubMed Raj A, Saitz R, Cheng DM, Winter M, Samet JH. Associations between alcohol, heroin, and cocaine use and high risk sexual behaviors among detoxification patients. Am J Drug Alcohol Abuse. 2007;33(1):169–78.CrossRefPubMed
11.
Zurück zum Zitat Rosengard C, Anderson BJ, Stein MD. Correlates of condom use and reasons for condom non-use among drug users. Am J Drug Alcohol Abuse. 2006;32(4):637–44.CrossRefPubMed Rosengard C, Anderson BJ, Stein MD. Correlates of condom use and reasons for condom non-use among drug users. Am J Drug Alcohol Abuse. 2006;32(4):637–44.CrossRefPubMed
12.
Zurück zum Zitat D’Aunno T, Pollack HA, Jiang L, Metsch LR, Friedmann PD. HIV testing in the nation’s opioid treatment programs, 2005-2011: the role of state regulations. Health Serv Res. 2014;49(1):230–48.CrossRefPubMed D’Aunno T, Pollack HA, Jiang L, Metsch LR, Friedmann PD. HIV testing in the nation’s opioid treatment programs, 2005-2011: the role of state regulations. Health Serv Res. 2014;49(1):230–48.CrossRefPubMed
13.
Zurück zum Zitat Substance abuse and mental health services Administration, Center for Behavioral Health Statistics and Quality. The N-SSATS report: HIV services offered by substance abuse treatment facilities. Rockville, M.D: Substance Abuse and Mental Health Services Administration; 2010. Substance abuse and mental health services Administration, Center for Behavioral Health Statistics and Quality. The N-SSATS report: HIV services offered by substance abuse treatment facilities. Rockville, M.D: Substance Abuse and Mental Health Services Administration; 2010.
14.
Zurück zum Zitat Metsch LR, Feaster DJ, Gooden L, et al. Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. Am J Public Health. 2012;102(6):1160–7.CrossRefPubMedPubMedCentral Metsch LR, Feaster DJ, Gooden L, et al. Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. Am J Public Health. 2012;102(6):1160–7.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Metcalf CA, Douglas JM Jr, Malotte CK, et al. Relative efficacy of prevention counseling with rapid and standard HIV testing: a randomized, controlled trial (RESPECT-2). Sex Transm Dis. 2005;32(2):130–8.CrossRefPubMed Metcalf CA, Douglas JM Jr, Malotte CK, et al. Relative efficacy of prevention counseling with rapid and standard HIV testing: a randomized, controlled trial (RESPECT-2). Sex Transm Dis. 2005;32(2):130–8.CrossRefPubMed
16.
Zurück zum Zitat Skinner HA. Assessment of substance abuse: drug abuse screening test. 2nd ed. Durham: Macmillan Reference USA; 2001. Skinner HA. Assessment of substance abuse: drug abuse screening test. 2nd ed. Durham: Macmillan Reference USA; 2001.
18.
Zurück zum Zitat NIAAA. Helping patients who drink too much: a clinician’s guide. Maryland: Bethesda; 2005. NIAAA. Helping patients who drink too much: a clinician’s guide. Maryland: Bethesda; 2005.
19.
Zurück zum Zitat Koblin BA, Husnik MJ, Colfax G, et al. Risk factors for HIV infection among men who have sex with men. Aids. 2006;20(5):731–9.CrossRefPubMed Koblin BA, Husnik MJ, Colfax G, et al. Risk factors for HIV infection among men who have sex with men. Aids. 2006;20(5):731–9.CrossRefPubMed
20.
Zurück zum Zitat Metsch LR, McCoy CB, McCoy HV, et al. HIV-related risk behaviors and seropositivity among homeless drug-abusing women in Miami, Florida. J Psychoact Drugs. 1995;27(4):435–46.CrossRef Metsch LR, McCoy CB, McCoy HV, et al. HIV-related risk behaviors and seropositivity among homeless drug-abusing women in Miami, Florida. J Psychoact Drugs. 1995;27(4):435–46.CrossRef
21.
Zurück zum Zitat Brafford LJ, Beck KH. Development and validation of a condom self-efficacy scale for college students. J Am Coll Health. 1991;39(5):219–25.CrossRefPubMed Brafford LJ, Beck KH. Development and validation of a condom self-efficacy scale for college students. J Am Coll Health. 1991;39(5):219–25.CrossRefPubMed
22.
Zurück zum Zitat DeHart DD, Birkimer JC. Trying to practice safer sex: development of the sexual risks scale. J Sex Res. 1997;34(1):11–25.CrossRef DeHart DD, Birkimer JC. Trying to practice safer sex: development of the sexual risks scale. J Sex Res. 1997;34(1):11–25.CrossRef
23.
Zurück zum Zitat Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573–83.CrossRefPubMed Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573–83.CrossRefPubMed
24.
25.
Zurück zum Zitat Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS. Random survival forests. Ann Appl Stat. 2008;2:841–60.CrossRef Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS. Random survival forests. Ann Appl Stat. 2008;2:841–60.CrossRef
26.
Zurück zum Zitat Ishwaran H, Kogalur UB. Random forests for survival, regression and classification (RF-SRC), R package version 1.6.1. 2015. Ishwaran H, Kogalur UB. Random forests for survival, regression and classification (RF-SRC), R package version 1.6.1. 2015.
27.
Zurück zum Zitat Xu, Ruo. “Improvements to random forest methodology”. Graduate Theses and Dissertations. 2013;Paper 13052. Xu, Ruo. “Improvements to random forest methodology”. Graduate Theses and Dissertations. 2013;Paper 13052.
28.
Zurück zum Zitat Friedman JH. Greedy function approximation: a gradient boosting machine. Ann Stat. 2001;29:1189–232.CrossRef Friedman JH. Greedy function approximation: a gradient boosting machine. Ann Stat. 2001;29:1189–232.CrossRef
29.
Zurück zum Zitat Ishwaran H. Variable importance in binary regression trees and forests. Electron J Stat. 2007;1:519–37.CrossRef Ishwaran H. Variable importance in binary regression trees and forests. Electron J Stat. 2007;1:519–37.CrossRef
31.
Zurück zum Zitat Shi M, He J. SNRFCB: sub-network based random forest classifier for predicting chemotherapy benefit on survival for cancer treatment. Mol BioSyst. 2016;12(4):1214–23.CrossRefPubMed Shi M, He J. SNRFCB: sub-network based random forest classifier for predicting chemotherapy benefit on survival for cancer treatment. Mol BioSyst. 2016;12(4):1214–23.CrossRefPubMed
32.
Zurück zum Zitat Xiao LH, Chen PR, Gou ZP, et al. Prostate cancer prediction using the random forest algorithm that takes into account transrectal ultrasound findings, age, and serum levels of prostate-specific antigen. Asian J Androl. 2016. Xiao LH, Chen PR, Gou ZP, et al. Prostate cancer prediction using the random forest algorithm that takes into account transrectal ultrasound findings, age, and serum levels of prostate-specific antigen. Asian J Androl. 2016.
33.
Zurück zum Zitat Stekhoven DJ, Bühlmann P. MissForest—non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012;28(1):112–8.CrossRefPubMed Stekhoven DJ, Bühlmann P. MissForest—non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012;28(1):112–8.CrossRefPubMed
34.
Zurück zum Zitat Noar SM, Cole C, Carlyle K. Condom use measurement in 56 studies of sexual risk behavior: review and recommendations. Arch Sex Behav. 2006;35(3):327–45.CrossRefPubMed Noar SM, Cole C, Carlyle K. Condom use measurement in 56 studies of sexual risk behavior: review and recommendations. Arch Sex Behav. 2006;35(3):327–45.CrossRefPubMed
35.
Zurück zum Zitat Fonner VA, Kennedy CE, O’Reilly KR, Sweat MD. Systematic assessment of condom use measurement in evaluation of HIV prevention interventions: need for standardization of measures. AIDS Behav. 2014;18(12):2374–86.CrossRefPubMedPubMedCentral Fonner VA, Kennedy CE, O’Reilly KR, Sweat MD. Systematic assessment of condom use measurement in evaluation of HIV prevention interventions: need for standardization of measures. AIDS Behav. 2014;18(12):2374–86.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Schroder KE, Carey MP, Vanable PA. Methodological challenges in research on sexual risk behavior: II. Accuracy of self-reports. Ann Behav Med. 2003;26(2):104–23.CrossRefPubMedPubMedCentral Schroder KE, Carey MP, Vanable PA. Methodological challenges in research on sexual risk behavior: II. Accuracy of self-reports. Ann Behav Med. 2003;26(2):104–23.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Segal MR, Barbour JD, Grant RM. Relating HIV-1 sequence variation to replication capacity via trees and forests. Stat Appl Genet Mol Biol. 2004;3(1):1–18. Segal MR, Barbour JD, Grant RM. Relating HIV-1 sequence variation to replication capacity via trees and forests. Stat Appl Genet Mol Biol. 2004;3(1):1–18.
38.
Zurück zum Zitat Xu S, Huang X, Xu H, Zhang C. Improved prediction of coreceptor usage and phenotype of HIV-1 based on combined features of V3 loop sequence using random forest. J Microbiol. 2007;45(5):441–6.PubMed Xu S, Huang X, Xu H, Zhang C. Improved prediction of coreceptor usage and phenotype of HIV-1 based on combined features of V3 loop sequence using random forest. J Microbiol. 2007;45(5):441–6.PubMed
Metadaten
Titel
Factors Associated with HIV Testing Among Participants from Substance Use Disorder Treatment Programs in the US: A Machine Learning Approach
verfasst von
Yue Pan
Hongmei Liu
Lisa R. Metsch
Daniel J. Feaster
Publikationsdatum
08.12.2016
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 2/2017
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-016-1628-y

Weitere Artikel der Ausgabe 2/2017

AIDS and Behavior 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.